Juno Therapeutics To Present Updated Data

Juno Therapeutics To Present Updated Data

Juno Therapeutics said it will present updates on its investigational products JCAR017 and JCAR014, currently being developed to target CD19, a protein expressed on the surface of almost all B cell malignancies, including non-Hodgkin lymphoma, chronic lymphocytic leukemia and acute lymphoblastic leukemia. New data from the ongoing phase 1 trial evaluating JCAR017 in adult patients with relapsed or refractory aggressive non-Hodgkin lymphoma -diffuse large B cell lymphoma, primary mediastinal B […]

Read More ˃
Netflix Expands Europe Operations

Netflix Expands Europe Operations

Netflix said Friday it is creating 400 jobs at its new European customer service hub which opened this week in Amsterdam. The company said the multilingual hub will initially employ a workforce of 170, growing to 345 by the end of 2017 and surpassing 400 by the end of 2018. The company also confirmed plans to announce at least six new European original projects before the end of 2017. The […]

Read More ˃
Federal Signal to Acquire Truck Bodies and Equipment

Federal Signal to Acquire Truck Bodies and Equipment

Federal Signal Corp. said pre-market Monday it has sealed an agreement to purchase Truck Bodies and Equipment International, a U.S-based maker of dump truck bodies and trailers, for $270 million. The company said the acquisition is slated to be immediately accretive to its margins and earnings per share and will enable it to strengthen its position as a specialty vehicle maker in maintenance and infrastructure markets. Federal Signal added it […]

Read More ˃
Sinclair Broadcast Q1 Results Beat Estimates

Sinclair Broadcast Q1 Results Beat Estimates

Sinclair Broadcast Group said Wednesday its Q1 diluted earnings were $0.61 per share, or $0.32 per share excluding the March gain on the sale of Alarm Funding Associates, compared with $0.25 per share in the same period a year ago. Analysts polled by Capital IQ had expected earnings of $0.31 per share. The company also reported revenue of $649.9 million, up from $578.9 million in the same period a year […]

Read More ˃
Exact Sciences Q1 Results Top Views

Exact Sciences Q1 Results Top Views

Exact Sciences said Thursday its Q1 loss was $0.32 per share, narrower than the $0.49 per share loss in the same period a year ago and better than the $0.41 per share loss expected by analysts at Capital IQ. Shares were up over 17% in recent pre-market, on track to hit a new high since July 2015 if gains hold through regular trade. The stock has a 52-week range of […]

Read More ˃